Abstract
Objective
This study evaluated the clinical, microbiological, and immunological results of poly lactic-co-glycolic acid (PLGA) nanospheres containing 20% doxycycline (DOXY) in the treatment of type-2 diabetic patients (DM-2) with chronic periodontitis (CP).
Material and methods
A parallel, double-blind, randomized, placebo-controlled clinical trial was conducted in DM-2 presenting severe and generalized CP. All patients received one-stage full-mouth ultrasonic debridement (FMUD) and they were randomly divided into two groups: PLAC (n = 20)—local application of placebo PLGA nanospheres, and DOXY (n = 20)—local application of doxycycline-loaded nanospheres; both in six non-contiguous sites. Clinical, metabolic (fasting plasma glucose level—FPG and glycated hemoglobin—HbA1c), cytokine pattern (multiplexed bead immunoassay) and microbiological assessments were performed at baseline, and 1, 3, and 6 months after treatment.
Results
Both groups showed clinical improvement in all parameters after treatment (p < 0.05). Deep pockets showed improvements in bleeding on probing—BoP (3 and 6 months), PD (at 3 months), and CAL gain (at 1 and 3 months) favoring DOXY (p < 0.05). The percentage of sites presenting PD reduction and CAL gain ≥ 2 mm was higher in DOXY at 3 months (p < 0.05). DOXY group exhibited a significant increase in the levels of anti-inflammatory interleukin (IL)-10 and a reduction in IL-8, IFN-y, IL-6, and IL-17 (p < 0.05), significant reduction in periodontal pathogens (p < 0.05), and a lower mean percentage of HbA1C at 3 months (p < 0.05).
Conclusion
DOXY nanospheres may be considered a potential adjunct to mechanical debridement in the therapy of periodontitis in DM-2, offering additional benefits in deep pockets, improving the cytokine profile, and reducing periodontal pathogen levels.
Clinical relevance
The use of locally applied doxycycline nanospheres may represent an adjunctive therapeutic approach in the treatment of periodontal disease in type-2 diabetic patients, achieving additional benefits in the local modulation of cytokines, microbial reduction, and clinical parameters, especially in deep pockets.
Similar content being viewed by others
References
Faria-Almeida R, Navarro A, Bascones A (2006) Clinical and metabolic changes after conventional treatment of type 2 diabetic patients with chronic periodontitis. J Periodontol 77:591–598. https://doi.org/10.1902/jop.2006.050084
Tamashiro NS, Duarte PM, Miranda TS, Maciel SS, Figueiredo LC, Faveri M, Feres M (2016) Amoxicillin plus metronidazole therapy for patients with periodontitis and type 2 diabetes: a 2-year randomized controlled trial. J Dent Res 95:829–836. https://doi.org/10.1177/0022034516639274
Grellmann AP, Sfreddo CS, Maier J, Lenzi TL, Zanatta FB (2016) Systemic antimicrobials adjuvant to periodontal therapy in diabetic subjects: a meta-analysis. J Clin Periodontol 43:250–260. https://doi.org/10.1111/jcpe.12514
Rovai ES, Souto ML, Ganhito JA, Holzhausen M, Chambrone L, Pannuti CM (2016) Efficacy of local antimicrobials in the non-surgical treatment of patients with periodontitis and diabetes: a systematic review. J Periodontol 87:1406–1417. https://doi.org/10.1902/jop.2016.160214
Souto MLS, Rovai ES, Ganhito JA, Holzhausen M, Chambrone L, Pannuti CM (2018) Efficacy of systemic antibiotics in nonsurgical periodontal therapy for diabetic subjects: a systematic review and meta-analysis. Int Dent J 68:207–220. https://doi.org/10.1111/idj.12384
O'Connell PA, Taba M, Nomizo A, Foss Freitas MC, Suaid FA, Uyemura SA, Trevisan GL, Novaes AB, Souza SL, Palioto DB, Grisi MF (2008) Effects of periodontal therapy on glycemic control and inflammatory markers. J Periodontol 79:774–783. https://doi.org/10.1902/jop.2008.070250
Matesanz-Perez P, Garcıa-Gargallo M, Figueroa E, Bascones-Martınez A, Sanz M, Herrera D (2013) A systematic review on the effects of local antimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in the treatment of chronic periodontitis. J Clin Periodontol 40:227–241. https://doi.org/10.1111/jcpe.12026
Kinane DF (2000) Local antimicrobial therapies in periodontal disease. Ann R Australas Coll Dent Surg 15:57–60
Gapski R, Hasturk H, Van Dyke TE, Oringer RJ, Wang S, Braun TM, Giannobile WV (2009) Systemic MMP inhibition for periodontal wound repair: results of a multi-centre randomized-controlled clinical trial. J Clin Periodontol 36:149–156. https://doi.org/10.1111/j.1600-051X.2008.01351.x
Agan S, Sonmez S, Serdar M (2006) The effect of topical doxycycline usage on gingival crevicular fluid MMP-8 levels of chronic and aggressive periodontitis patients: a pilot study. Int J Dent Hyg 4:114–121. https://doi.org/10.1111/j.1601-5037.2006.00174.x
Gurkan A, Emingil G, Cinarcik S, Berdeli A (2008) Post-treatment effects of subantimicrobial dose doxycycline on clinical parameters and gingival crevicular fluid transforming growth factor-beta1 in severe, generalized chronic periodontitis. Int J Dent Hyg 6:84–92. https://doi.org/10.1111/j.1601-5037.2007.00268.x
Golub LM, Lee HM, Stoner JA, Sorsa T, Reinhardt RA, Wolff MS, Ryan ME, Nummikoski PV, Payne JB (2008) Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women. J Periodontol 79:1409–1418. https://doi.org/10.1902/jop.2008.070623
Moura LA, Oliveira Giorgetti Bossolan AP, de Rezende Duek EA, Sallum EA, Nociti FH Jr, Casati MZ, Sallum AW (2012) Treatment of peri-implantitis using nonsurgical debridement with bioresorbable nanospheres for controlled release of doxycycline: a case report. Compend Contin Educ Dent 33:145–149
Moura LA, Ribeiro FV, Aiello TB, Duek EA, Sallum EA, Nociti Junior FH, Casati MZ, Sallum AW (2015) Characterization of the release profile of doxycycline by PLGA microspheres adjunct to non-surgical periodontal therapy. J Biomater Sci Polym Ed 26:573–584. https://doi.org/10.1080/09205063.2015.1045249
Dickers KJ, Milroy GE, Huatan H, Cameron RE (2002) The use of biodegradable polymers in drug delivery systems to provide pre-programmed release. Cambridge Centre for Medical Materials, University of Cambridge; The Drug Delivery Companies Report Autumn/Winter 2002
Bogren A, Teles RP, Torresyap G, Haffajee AD, Socransky SS, Wennström JL (2008) Locally delivered doxycycline during supportive periodontal therapy: a 3-year study. J Periodontol 79:827–835. https://doi.org/10.1902/jop.2008.070515
Dawes GJS, Fratila-Apachitei LE, Mulia K, Apachitei I, Witkamp G-J, Duszczyk J (2009) Size effect of PLGA spheres on drug loading efficiency and release profiles. J Mater Sci Mater Med 20:1089–1094. https://doi.org/10.1007/s10856-008-3666-0
Santos VR, Lima JA, De Mendonça AC, Braz Maximo MB, Faveri M, Duarte PM (2009) Effectiveness of full-mouth and partial-mouth scaling and root planing in treating chronic periodontitis in subjects with type 2 diabetes. J Periodontol 80:1237–1245. https://doi.org/10.1902/jop.2009.090030
Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1–6
Ainamo J, Bay I (1975) Problems and proposals for recording gingivitis and plaque. Int Dent J 25:229–235
Casarin RC, Ribeiro Edel P, Mariano FS, Nociti FH Jr, Casati MZ, Gonçalves RB (2010) Levels of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, inflammatory cytokines and species-specific immunoglobulin G in generalized aggressive and chronic periodontitis. J Periodontal 45:635–642. https://doi.org/10.1111/j.1600-0765.2010.01278.x
Casarin RC, Peloso Ribeiro ED, Sallum EA, Nociti FH Jr, Gonçalves RB, Casati MZ (2012) The combination of amoxicillin and metronidazole improves clinical and microbiologic results of one-stage, full-mouth, ultrasonic debridement in aggressive periodontitis treatment. J Periodontol 83(8):988–998. https://doi.org/10.1902/jop.2012.110513
Tsalikis L, Sakellari D, Dagalis P, Boura P, Konstantinidis A (2014) Effects of doxycycline on clinical, microbiological and immunological parameters in well-controlled diabetes type-2 patients with periodontal disease: a randomized, controlled clinical trial. J Clin Periodontol 41:972–980. https://doi.org/10.1111/jcpe.12287
Botero JE, Yepes FL, Ochoa SP, Hincapie JP, Roldan N, Ospina CA, Castrillon CA, Becerra MA (2013) Effects of periodontal non-surgical therapy plus azithromycin on glycemic control in patients with diabetes: a randomized clinical trial. J Periodontal Res 48:706–712
Ramos UD, Ayub LG, Reino DM, Grisi MF, Taba M Jr, Souza SL, Palioto DB, Novaes AB Jr (2016) Antimicrobial photodynamic therapy as an alternative to systemic antibiotics: results from a double-blind, randomized, placebo-controlled, clinical study on type 2 diabetics. J Clin Periodontol 43:147–155. https://doi.org/10.1111/jcpe.12498
Al-Zahrani MS, Bamshmous SO, Alhassani AA, Al-Sherbini MM (2009) Short-term effects of photodynamic therapy on periodontal status and glycemic control of patient with diabetes. J Periodontol 80:1568–1573. https://doi.org/10.1902/jop.2009.090206
Gaikwad SP, Gurav AN, Shete AR, Desarda HM (2013) Effect of scaling and root planning combined with systemic doxycycline therapy on glycemic control in diabetes mellitus subjects with chronic generalized periodontitis: a clinical study. J Periodontal Implant Sci 43:79–86. https://doi.org/10.5051/jpis.2013.43.2.79
Kaur PK, Narula SC, Rajput RK, Sharma R, Tewari S (2015) Periodontal and glycemic effects of nonsurgical periodontal therapy in patients with type 2 diabete stratified by baseline HbA1c. J Oral Sci 57:201–211. https://doi.org/10.2334/josnusd.57.201
Teeuw WJ, Gerdes VE, Loos BG (2010) Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care 33:421–427
Miranda TS, Feres M, Perez-Chaparro PJ, Faveri M, Figueiredo LC, Tamashiro NS, Bastos MF, Duarte PM (2014) Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1-year outcomes of a randomized placebo-controlled clinical trial. J Clin Periodontol 41:890–899. https://doi.org/10.1111/jcpe.12282
Martorelli de Lima AF, Cury CC, Palioto DB, Duro AM, da Silva RC, Wolff LF (2004) Therapy with adjunctive doxycycline local delivery in patients with type 1 diabetes mellitus and periodontitis. J Clin Periodontol 31:648–653. https://doi.org/10.1111/j.0303-6979.2004.00576
Javed F, Ahmed HB, Mehmood A, Bain C, Romanos GE (2014) Effect of nonsurgical periodontal therapy (with or without oral doxycycline delivery) on glycemic status and clinical periodontal parameters in patients with prediabetes: a short-term longitudinal randomized case-control study. Clin Oral Investig 18:1963–1968. https://doi.org/10.1007/s00784-014-1185-6
Machion L, Andia DC, Lecio G, Nociti FH Jr, Casati MZ, Sallum AW, Sallum EA (2006) Locally delivered doxycycline as an adjunctive therapy to scaling and root planing in the treatment of smokers: a 2-year follow-u. J Periodontol 77:606–613. https://doi.org/10.1902/jop.2006.050087
Ciancio SG (1999) Site specific delivery of antimicrobial agents for periodontal disease. Gen Dent 47:172–8, 181
Srirangarajan S, Mundargi RC, Ravindra S, Setty SB, Aminabhavi TM, Thakur S (2011) Randomized, controlled, single-masked, clinical study to compare and evaluate the efficacy of microspheres and gel in periodontal pocket therapy. J Periodontol 82:114–121. https://doi.org/10.1902/jop.2010.100324
Madianos PN, Koromantzos PA (2018) An update of the evidence on the potential impact of periodontal therapy on diabetes outcomes. J Clin Periodontol 45:188–195. https://doi.org/10.1111/jcpe.12836
Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87–113. https://doi.org/10.1111/j.1600-065X.2008.00628.x
Golub LM, Elburki MS, Walker C, Ryan M, Sorsa T, Tenenbaum H, Goldberg M, Wolff M, Gu Y (2016) Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases. Int Dent 66:127–135. https://doi.org/10.1111/idj.12221
Bastos MF, Tucci MA, de Siqueira A, de Faveri M, Figueiredo LC, Vallim PC, Duarte PM (2016) Diabetes may affect the expression of matrix metalloproteinases and their inhibitors more than smoking in chronic periodontitis. J Periodontal Res 52:292–299. https://doi.org/10.1111/jre.12394
Funding
The present study was carried out with support from Research Support Foundation of the State of São Paulo—FAPESP (process number 2012/50877-3 and 2012/22492-0).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lecio, G., Ribeiro, F.V., Pimentel, S.P. et al. Novel 20% doxycycline-loaded PLGA nanospheres as adjunctive therapy in chronic periodontitis in type-2 diabetics: randomized clinical, immune and microbiological trial. Clin Oral Invest 24, 1269–1279 (2020). https://doi.org/10.1007/s00784-019-03005-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-019-03005-9